Aspergillus Tracheobronchitis
- 1 September 2012
- journal article
- case report
- Published by Ovid Technologies (Wolters Kluwer Health) in Medicine
- Vol. 91 (5), 261-273
- https://doi.org/10.1097/md.0b013e31826c2ccf
Abstract
Aspergillus tracheobronchitis (AT) is an infrequent but severe form of invasive pulmonary aspergillosis in which the fungal infection is entirely or predominantly confined to the tracheobronchial tree. We reviewed 8 cases of AT diagnosed in our tertiary care center during an 18-year period, as well as 148 cases previously reported in the English literature from 1985 to July 2011. The demographic, clinical, imaging, bronchoscopic, and outcome characteristics of every eligible patient were excerpted, and predictors of inhospital mortality were identified by logistic regression. Solid organ transplantation (SOT) (44.2%), hematologic malignancy (21.2%), neutropenia (18.7%), and chronic obstructive pulmonary disease (15.4%) were the most common underlying conditions reported. Most cases occurred in patients receiving long-term corticosteroid treatment (71.8%) or chemotherapy (25.0%). Fever and respiratory complaints (cough, dyspnea, stridor, or wheezing) were the most frequent symptoms; one-third of patients developed acute respiratory distress at presentation, and 15.1% were asymptomatic at the time of diagnosis. Initial imaging studies were not informative in 47.4% of the cases. Aspergillus fumigatus was the predominant species (74.4%). The pseudomembranous form was the most commonly observed (31.9% of cases) and was more frequent in neutropenic patients (p = 0.007), whereas ulcerative AT (31.2%) was associated with SOT (p = 0.001). The most frequent antifungal monotherapy regimens were amphotericin B deoxycholate (23.1%) and itraconazole (18.6%), whereas combined therapy was administered in 35.9% of the cases. Overall inhospital mortality was 39.1%, with neutropenia (odds ratio [OR], 20.47; p < 0.001) and acute respiratory distress at presentation (OR, 9.54; p = 0.002) as independent prognostic factors. Our pooled analysis of the literature shows that AT remains a rare opportunistic infection with a nonspecific presentation and a variable course depending on the nature of the predisposing factor.Keywords
This publication has 65 references indexed in Scilit:
- Pseudomembranous tracheobronchial aspergillosis: a rare manifestation of invasive aspergillosis in a non‐neutropenic patient with Hodgkin's diseaseMycoses, 2003
- Nodular invasive tracheobronchitis due to Aspergillus in a patient with systemic lupus erythematosus.Lupus, 2002
- Aspergillus laryngotracheobronchial infection in a 6-year-old girl following bone marrow transplantationInternational Journal of Pediatric Otorhinolaryngology, 2001
- Topical amphotericin B application in severe bronchial aspergillosis after lung transplantation: report of experiences in 3 casesThe Journal of Heart and Lung Transplantation, 2000
- Pseudomembranous necrotizing bronchial aspergillosis.The British Journal of Radiology, 2000
- Successful treatment of post-influenza pseudomembranous necrotising bronchial aspergillosis with liposomal amphotericin, inhaled amphotericin B, gamma interferon and GM-CSFThorax, 1999
- Simultaneous Obstructing and Pseudomembranous Necrotizing Tracheobronchitis Due toAspergillus flavusClinical Infectious Diseases, 1998
- Pulmonary aspergillosis and massive haemoptysis in systemic lupus erythematosusClinical Intensive Care, 1996
- Successful Treatment of Invasive Bronchial Aspergillosis After Single-Lung TransplantationClinical Infectious Diseases, 1994
- Acute Airway Obstruction Due to Necrotizing Tracheobronchial Aspergillosis in Immunocompromised Patients: A New Clinical EntityAnnals of Otology, Rhinology & Laryngology, 1989